Charles Mowbray

11PUBLICATIONS
70CO-AUTHORS
Pharmaceutical delivery technologiesCheminformatics and quantitative structure-activity relationshipsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)VictimsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 14, 2026
Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis.

Rasmus Hansen Henninger, Wietse M Schouten, Byron Arana

|Mar 31, 2025
Discovery and Early Optimization of 1H-Indole-2-carboxamides with Anti-Trypanosoma cruzi Activity.

Ramon G de Oliveira, Luiza R Cruz, Marco A Dessoy

|Oct 26, 2024
Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis.

Andrea Lafleur, Stephane Daffis, Charles Mowbray

|Aug 30, 2024
The case for a global therapeutics development coalition: Building a therapeutics pipeline for pandemic and endemic diseases.

Shingai Machingaidze, Carmen Pérez Casas, Sheila Mburu

|May 27, 2024
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives.

Brian W Slafer, Marco A Dessoy, Ramon G de Oliveira

|Jul 03, 2023
Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in Mice.

Irfan Ullah, Fanny Escudie, Ivan Scandale

Pageof 2